Anne Schnepf

Dr. Anne Schnepf

Department of Biometry, Epidemiology and Information Processing, University of Veterinary Medicine Hannover, Foundation, Hanover, Germany
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2021 in Frontiers in Veterinary Science
Verified
Journal Article
Open access
PDF file
ASAnne Schnepf
Anne Schnepf
SKSabine Kramer
Sabine Kramer
RWRolf Wagels
Rolf Wagels
HVHolger A. Volk
Holger A. Volk
LKLothar Kreienbrock
Lothar Kreienbrock
In contrast to food-producing animals, where the documentation of the usage of antimicrobials is regulated by law, antimicrobial usage (AMU) in dogs and cats is only sparsely monitored. We collected data generated by an electronic practice management software (EPMS) between January 1, 2017 and December 31, 2018 to investigate AMU. All information was obtained from clinical routine data from the Department of Small Animal Medicine and Surgery (DSAM), University of Veterinary Medicine Hannover (TiHo). In 2017, 78,076 drug administrations were documented for 5,471 dogs and cats, of which 14,020 (17.96%) were antimicrobial drugs (AMs) specifically documented in 2,910 (51.31%) dogs and cats. In 2018, 104,481 drug administrations were documented for 5,939 dogs and cats. Of these drug administrations, 18,170 (17.39%) AM administrations were documented for 3,176 (53.48%) dogs and cats. Despite the increasing documentation of AM administrations, differences between 2017 and 2018 were not statistically significant [odds ratio (OR), 1.01; 95% confidence interval (CI), 0.98–1.03]. Prescription diversity (PD) in 2017 for dogs was 0.92 and for cats 0.89. In 2018, PD for dogs was 0.93 and for cats 0.88. As well as the documented number of AM administrations, the documented amount of active ingredients administered in 2018 (total: 17.06 kg; dogs: 16.11 kg, cats: 0.96 kg) increased compared with 2017 (total: 15.60 kg; dogs: 14.80 kg, cats: 0.80 kg). In 2017 and 2018, the most commonly administered antimicrobial groups were penicillins, nitroimidazoles, and quinolones for dogs and cats, respectively. While the in-house point-of-care administration accounts for the largest share of the documented amount of AMs administered, the highest number of documented AM administrations was assigned to inpatient care in 2017 and 2018, respectively. However, AM administration in outpatient care remained the lowest in both years. Since no statistically significant difference in AM administrations was observed between 2017 and 2018 and the most commonly used AMs at the DSAM were ranked, data can be used as a baseline to evaluate how changes in in-house guidelines and future legal requirements affect the prescribing culture. Data generated within the DSAM should be evaluated annually.

29 April 2020 in Frontiers in Veterinary Science
Verified
Journal Article
Open access
PDF file
ASAnne Schnepf
Anne Schnepf
ABAstrid Bienert-Zeit
Astrid Bienert-Zeit
HEHatice Ertugrul
Hatice Ertugrul
RWRolf Wagels
Rolf Wagels
NWNicole Werner
Nicole Werner
LKLothar Kreienbrock
Lothar Kreienbrock
The usage of antimicrobial drugs (AMs) leads to an increase in antimicrobial resistance (AMR). Although different antimicrobial usage (AMU) monitoring programs exist for livestock animals in Germany, there is no such system for horses. However, with the increasing usage of electronic practice management software (EPMS), it is possible to analyze electronic field data generated for routine purposes. The aim of this study was to generate AMU data for German horses with data from the Clinic for Horses (CfH), University of Veterinary Medicine Hannover (TiHo), and in addition to show that different processes of data curation are necessary to provide results, especially considering quantitative indices. In this investigation, the number of antimicrobial doses used and the amount and percentage of active ingredients applied were calculated. Data contained all drugs administered between the 1st of January and the 31st of December 2017. A total of 2,168 horses were presented for veterinary care to the CfH and 34,432 drug applications were documented for 1,773 horses. Of these, 6,489 (18.85%) AM applications were documented for 837 (47.21%) horses. In 2017, 162.33 kg of active ingredients were documented. The most commonly used antibiotic classes were sulfonamides (84.32 kg; 51.95 %), penicillins (30.11 kg; 18.55%) and nitroimidazoles (24.84 kg; 15.30%). In 2017, the proportion of Critically Important Antibiotics (CIA)—Highest Priority used was 0.15% (0.24 kg) and the proportion of CIA—High Priority used was 20.85% (33.85 kg). Of the total 9,402 entries of antimicrobial active ingredients, the three with the largest number used were sulfonamides [n = 2,798 (29.76%)], trimethoprim [n = 2,757 (29.76%)] and aminoglycosides [n = 1,381 (14.69%)]. Comparison between Administered Daily Dose (ADA) and Recommended Daily Dose of CfH (RDDCfH), showed that 3.26% of ADA were below RDDCfH, 3.18% exceeded RDDCfH and 93.55% were within the range around RDDCfH. This study shows that data generated by an EPMS can be evaluated once the method is set up and validated. The method can be transferred to evaluate data from the EPMS of other clinics or animal species, but the transferability depends on the quality of AMU documentation and close cooperation with respective veterinarians is essential.

16 December 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
CBClarissa Bonzelett
Clarissa Bonzelett
ASAnne Schnepf
Anne Schnepf
MHMaria Hartmann
Maria Hartmann
AKAnnemarie Käsbohrer
Annemarie Käsbohrer
LKLothar Kreienbrock
Lothar Kreienbrock
Antimicrobial usage in both human and veterinary medicine is considered one of the main drivers of antimicrobial resistance; its reduction poses a serious challenge. To analyse the associations between usage and resistance, data from monitoring systems and classification of all antimicrobial substances are crucial. In this analysis, we investigated longitudinal data collected between 2013 and 2020 within the Veterinary Consumption of Antibiotics project from pig farms in Germany, including all antimicrobial classes, but focusing on critically important antimicrobials: third- and fourth-generation cephalosporins, fluoroquinolones, macrolides, and polymyxins. Analysing the treatment frequency, we found that a reduction in antimicrobial use in all types of pig production has occurred over time, accompanied by a rising percentage of farms without any usage. The lists of the World Health Organisation, World Organisation for Animal Health, and European Medicine Agency classify different antimicrobial substances as critically important. The vast differences between the respective weighted treatment frequencies allocated to the antimicrobials of main interest reflect the huge impact of the three categorisation systems. We concluded that, with the aim of creating national treatment guidelines supporting veterinarians to make treatment decisions, the list of the European Medicine Agency is the most suitable.

16 November 2022 in Veterinary Record
Verified
Journal Article
Open access
NKNatália Korytárová
Natália Korytárová
SKSabine Kramer
Sabine Kramer
ASAnne Schnepf
Anne Schnepf
LKLothar Kreienbrock
Lothar Kreienbrock
HVHolger Volk
Holger Volk
Background: Excessive use of antimicrobials and the increasing occurrence of antimicrobial resistance are major challenges in both human and veterinary medicine. The role of prophylactic antimicrobial therapy in orthopaedic and neurosurgeries in dogs can be questioned. The aim of this study was to evaluate the rate of surgical site infections (SSI) and urinary tract infections (UTI) in dogs after cessation of antibiotics following spinal surgery. Methods: Electronic patient records from January 2018 to December 2019 were retrospectively reviewed to identify dogs that underwent spinal surgery ( n = 158). Antimicrobial drug use and the presence of SSI and UTI were recorded. Results: Overall, SSI developed in 1.3% of dogs that underwent spinal surgery, while UTI developed in 8.2%. Multidrug‐resistant (MDR) bacteria were detected in 5.1% of dogs. The rates of SSI, UTI and MDR did not differ significantly between dogs that received postoperative antimicrobial therapy and those that did not. Limitations: The main limitation of this study was its retrospective design. Conclusion: Overall, the SSI rate in this study was low. Cessation of postoperative antimicrobial use in dogs following spinal surgery did not have a negative effect on either SSI development or the occurrence of UTI.

6 February 2024 in Zoonotic Diseases
Verified
Journal Article
Open access
PDF file
ASAnne Schnepf
Anne Schnepf
KHKatja Hille
Katja Hille
GMGesine van Mark
Gesine van Mark
TWTristan Salomon Winkelmann
Tristan Salomon Winkelmann
KRKaren Remm
Karen Remm
LKLothar Kreienbrock
Lothar Kreienbrock
Two-thirds of human infectious diseases are zoonotic diseases and routine data collections exist for each sector (human, veterinary, environmental). However, these operate separately and the collected data are not integrated across sectors. Publicly available information on these routine data collections in terms of metadata and the information collected is sparse. The aim was to create an inventory of routine data collections in the Federal State of Lower Saxony, Germany. A systematic screening of existing routine data collections from the human and veterinary sectors on zoonotic infectious diseases was carried out on the basis of expert interviews. A standardised template was used to collect relevant metadata on data collections and pathogens they contain. The template was transferred to Research Electronic Data Capture tools. We recorded metadata for 19 veterinary, 16 human and 2 other data collections, and for 69 different zoonotic pathogens. The frequencies of a selection of metadata were analysed descriptively. The data collections, which served different purposes, differed, e.g., in underlying population and sampling strategy, export format and access to the original data. We identified challenges for integrated analyses of data from different collections, which need to be addressed to develop a One Health monitoring and surveillance system.

26 April 2022 in Das Gesundheitswesen
Verified
Journal Article
Closed access
KHKatja Hille
Katja Hille
GMGesine van Mark
Gesine van Mark
ASAnne Schnepf
Anne Schnepf
KKKatrin Kunze
Katrin Kunze
MSMartina Scharlach
Martina Scharlach
LKLothar Kreienbrock
Lothar Kreienbrock
Obwohl etwa 2/3 der Infektionskrankheiten beim Menschen durch Zoonoseerreger verursacht werden, ist die gemeinsame Überwachung von Infektionsereignissen bei Menschen und Tieren weiterhin die Ausnahme. Auch viele antibiotikaresistente Erreger sind als One-Health-relevant zu bewerten. Um Monitoring und Surveillance von zoonotischen und antibiotikaresistenten Erregern zu verbessern, zielt das Projekt "Connect One Health Data" darauf ab, Daten aus dem Gesundheitswesen und der Veterinärbehördlichen-Überwachung zu integrieren (www.one-health-hannover.de). Im Rahmen des Projektes werden zu Datenquellen aus Deutschland und Niedersachsen, die Informationen zu zoonotischen und antibiotikaresistenten Erregern enthalten, Metadaten erfasst. Auf Ebene der Datenquelle werden z.B. die untersuchte Population, der Zweck der Datensammlung und die Verfügbarkeit der Daten erfasst. Zu allen relevanten Erregern werden weitere Informationen wie die Labormethode oder zeitliche und räumliche Auflösung der Daten aufgenommen. Die Machbarkeit einer gemeinsamen Analyse von Daten aus verschiedenen Routinedatensammlungen (integrierten Datenanalyse) soll in Anwendungsfällen getestet und bewertet werden. Dies beinhaltet auch eine juristische, datenschutzrechtliche Prüfung. Bislang wurden 36 One Health-relevante Datenquellen aufgenommen. Davon 16 aus dem Bereich Humanmedizin und Gesundheitswesen, 17 aus dem Bereich der veterinärbehördlichen Überwachung (Tiere, Betriebe, Lebensmittel, Futter) und 3 Datenquellen aus dem Bereich Umwelt. Ein erstes Ergebnis des Projektes ist eine Datenbank in der diese Datenquellen dokumentiert sind. Die Projekt-Datenbank ermöglicht die Suche nach Datenquellen, in denen bestimmte Erreger dokumentiert sind. In der Datenbank sind aktuelle mehr als 300 Erreger-Datensätze enthalten, die 150 unterschiedliche Erregerarten abbilden. Die Erreger, die in den meisten Datenquellen (DQ) vorkommen sind, E. coli (13 DQ), Campylobacter (9 DQ), MRSA (9 DQ), Salmonella (9 DQ), Staphylococcus (8 DQ). Neben der Erfassung weiterer Datenquellen werden derzeit am Beispiel von Campylobacter spp. Originaldaten auf Datenqualität und -vollständigkeit geprüft und analysiert, ob es z.B. zeitliche Zusammenhänge von Nachweisen in unterschiedlichen Datenquellen gibt. Im Rahmen des BVÖGD-Kongresses möchten wir einen Überblick der One Health-relevanten Datenquellen in Deutschland und Niedersachsen geben und die aktuellen Ergebnisse der Datenanalyse vorstellen. Interessenskonflikte Hiermit erklären die Autoren, dass zum Projekt und dessen Vorstellung keine Interessenkonflikte vorliegen. Publication Date: 26 April 2022 (online) © 2022. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14,70469 Stuttgart, Germany